The latest release of ACUSON Juniper, a Siemens Healthineers ultrasound system, now features the ACUSON Liver Suite to enable early detection and routine monitoring, making it suitable for population-level MASLD screening. With ACUSON Juniper, clinicians can make fast, non-invasive assessments in just one minute.1 Integrated UDFF and pSWE technologies give reliable, actionable insights to identify and monitor liver disease early – enabling proactive, efficient care for every patient.
Clinically validated ultrasound solutions give healthcare providers the confidence to see more, act sooner and deliver better outcomes. ACUSON Juniper delivers consistency and confidence in every result with a portfolio of imaging tools for liver care including:
- Ultrasound-derived fat fraction (UDFF) to quantify hepatic fat in good agreement with MRI-PDFF for MASLD screening
- pSWE to quantify liver stiffness to assess chronic liver disease
- Contrast-enhance ultrasound (CEUS) for enhanced lesion characterization
- Needle visualization for safe, precise targeting during liver biopsies and interventions
- Single crystal transducers for improved penetration with high resolution
With ACUSON Juniper clinicians can detect steatosis and assess its progression – non-invasively, at low cost and at scale, unlocking the potential to reverse liver disease and improve global health.
1 Data on file
